Eckert & Ziegler Strahlen und Medizintechnik (EUZ) Price & Analysis

1 Followers

EUZ Stock Chart & Stats

CHF12.76

CHF0.00(0.00%)

At close: Jul 30 4:00 PM EDT

CHF12.76

CHF0.00(0.00%)

Day’s Range― - ―

52-Week RangeCHF12.27 - CHF13.09

Previous CloseN/A

Volume0.00

Average Volume (3M)N/A

Market Cap

CHF765.28M

Enterprise ValueCHF892.81

Total Cash (Recent Filing)CHF110.33M

Total Debt (Recent Filing)CHF41.04M

Price to Earnings (P/E)16.4

Beta1.10

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.80

Shares Outstanding63,515,797

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio0.41

Price to Book (P/B)3.79

Price to Sales (P/S)3.06

P/FCF Ratio27.76

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF20.59

Price Target Upside61.35% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)0.77

Revenue Forecast (FY)CHF298.38M

Bulls Say, Bears Say

Bulls Say

Strong And Consistent ProfitabilityHigh gross and operating margins indicate differentiated, specialized offerings and pricing power. Sustained profitability provides internal funding for research, capacity, and compliance investments while supporting resilience across the business cycle.

Conservative Balance SheetLow leverage gives EUZ financial flexibility to invest in regulated infrastructure, pursue growth opportunities, and absorb operating volatility without excessive interest or refinancing pressure. Strong returns on equity also indicate effective use of its capital base.

Regulated Recurring-demand Business ModelRadioisotopes and radiation sources require specialized handling, licensed infrastructure, and compliance capabilities. Recurring replenishment needs and customer reliance on certified supply chains can support durable relationships and entry barriers over the medium term.

Bears Say

Recent Revenue SlowdownThe latest contraction suggests that recent demand or delivery timing has weakened after several years of expansion. If sustained, slower top-line growth could limit operating leverage and make the company more dependent on margin discipline.

Weakening Free Cash FlowA declining free-cash-flow base can reduce internally funded capacity for production expansion, technology development, and regulatory infrastructure. Continued weakness would make reported earnings less supportive of long-term reinvestment and shareholder returns.

Moderate Earnings-to-cash ConversionCash generation remains positive, but conversion below net income indicates working-capital needs, reinvestment, or other non-cash earnings effects. Persistent conversion gaps could constrain liquidity available for growth despite strong accounting profitability.

Eckert & Ziegler Strahlen und Medizintechnik News

Eckert & Ziegler Strahlen und Medizintechnik (0NZY) Unveils Dividend Details for Q3: Mark Your Calendar!

Eckert & Ziegler Strahlen und Medizintechnik (LSE: 0NZY) has declared, under its dividend policy, a yearly cash dividend...

2y ago

EUZ FAQ

What was Eckert & Ziegler Strahlen- und Medizintechnik AG’s price range in the past 12 months?

Eckert & Ziegler Strahlen- und Medizintechnik AG lowest stock price was CHF12.27 and its highest was CHF13.09 in the past 12 months.

What is Eckert & Ziegler Strahlen- und Medizintechnik AG’s market cap?

Eckert & Ziegler Strahlen- und Medizintechnik AG’s market cap is CHF765.28M.

When is Eckert & Ziegler Strahlen- und Medizintechnik AG’s upcoming earnings report date?

Eckert & Ziegler Strahlen- und Medizintechnik AG’s upcoming earnings report date is Nov 12, 2026 which is in 75 days.

How were Eckert & Ziegler Strahlen- und Medizintechnik AG’s earnings last quarter?

Eckert & Ziegler Strahlen- und Medizintechnik AG released its earnings results on Aug 13, 2026. The company reported CHF0.18 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Eckert & Ziegler Strahlen- und Medizintechnik AG overvalued?

According to Wall Street analysts Eckert & Ziegler Strahlen- und Medizintechnik AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Eckert & Ziegler Strahlen- und Medizintechnik AG pay dividends?

Eckert & Ziegler Strahlen- und Medizintechnik AG does not currently pay dividends.

What is Eckert & Ziegler Strahlen- und Medizintechnik AG’s EPS estimate?

Eckert & Ziegler Strahlen- und Medizintechnik AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Eckert & Ziegler Strahlen- und Medizintechnik AG have?

Eckert & Ziegler Strahlen- und Medizintechnik AG has 63,515,797 shares outstanding.

What happened to Eckert & Ziegler Strahlen- und Medizintechnik AG’s price movement after its last earnings report?

Eckert & Ziegler Strahlen- und Medizintechnik AG reported an EPS of CHF0.18 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Eckert & Ziegler Strahlen- und Medizintechnik AG?

Currently, no hedge funds are holding shares in CH:EUZ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Eckert & Ziegler Strahlen und Medizintechnik Stock Smart Score

Neutral

Fundamentals

Return on Equity

1.56%

Trailing 12-Months

Asset Growth

8.04%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.

Eckert & Ziegler Strahlen und Medizintechnik (EUZ) Earnings & Revenues

Historic Earnings Reports

EUZ Stock 12 Month Forecast

Average Price Target

CHF20.59

▲(61.35% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"CHF11","22":"CHF22","13.75":"CHF13.75","16.5":"CHF16.5","19.25":"CHF19.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.52348878,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF21.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.58768492,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF20.59</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.65188106,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF19.65</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,13.75,16.5,19.25,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.759,13.433191444615385,14.10738288923077,14.781574333846155,15.45576577846154,16.129957223076925,16.80414866769231,17.47834011230769,18.15253155692308,18.82672300153846,19.50091444615385,20.17510589076923,20.849297335384616,{"y":21.52348878,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.759,13.361206532307692,13.963413064615384,14.565619596923078,15.16782612923077,15.770032661538462,16.372239193846156,16.974445726153846,17.57665225846154,18.178858790769233,18.781065323076923,19.383271855384617,19.98547838769231,{"y":20.58768492,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.759,13.289221620000001,13.81944324,14.34966486,14.87988648,15.4101081,15.940329720000001,16.47055134,17.00077296,17.53099458,18.0612162,18.591437820000003,19.121659440000002,{"y":19.65188106,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.759,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":12.759,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >